Internet delivered mindfulness-based cognitive therapy (iMBCT) for chronic pain: A pilot randomised controlled trial

Not Applicable

Completed

• Conditions: Chronic Pain; Persistent Pain; Musculoskeletal - Other muscular and skeletal disorders; Anaesthesiology - Pain management

• Registration Number: ACTRN12623000833662
• Lead Sponsor: Chronic Pain Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-08-03
• Study Completion: 2024-03-06
• Last Update Posted: 22 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

(1) age of at least 18 years; (2) chronic pain (3 months or more, with pain experienced on at least 50% of days); (3) average intensity of pain 4 or higher on a 11-point NRS for most days of the previous 3 months; (4) able to read, speak, and understand English to comprehend the worksheets, measures and intervention implemented; (5) if currently taking analgesic or psychotropic medication, they must have been stabilized for at least 4 weeks prior to this study; (6) availability of a telephone, computer/laptop/tablet, and daily internet access; and (7) living in Australia at the time of study participation.

Exclusion Criteria

(1) severe cognitive impairment, as evidenced by two or more error(s) on the Six-Item Screener; (2) current alcohol or substance dependence; (3) uncontrolled schizophrenia or bipolar affective disorder; (4) chronic pain due to malignancy (e.g., cancer) or autoimmune disorders (e.g., lupus), headache as the primary source of pain, or a pain condition for which surgery is recommended and/or planned; and, (5) currently receiving other psychosocial treatments for any pain condition (as this may influence the treatment results).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umerical Rating Scale (NRS) of current, least, worst & average pain in past week which will be calculated as a composite score of characteristic pain intensity[ Pre-treatment (baseline), mid-treatment (2 weeks post-commencement of iMBCT or the treatment as usual waiting period) and post-treatment (post-completion of final module, 4 weeks post-commencement of iMBCT or the treatment as usual waiting period)]